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Abstract The role of the Ca2+-activated tyrosine kinase, Pyk2,
in the pleiotropic coupling of nerve cell stimulation to the MAP
kinase cascade still remains undefined. Using a panel of PC12
clones, one of which was defective in Pyk2, we demonstrate (1)
that the MAP kinase response induced by a [Ca2+]i rise
(following application of the Ca2+ ionophore, ionomycin) is
inappreciable in the defective clone and is re-established after
Pyk2 transfection; and (2) that the responses to both protein
kinase C and P2y2 receptor activation occur normally even in the
defective cells. We conclude that Pyk2 is the key mediator in the
pathway activated by Ca2+ but has minor roles with the other
types of stimulation.
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1. Introduction
In nerve cells, growth, di¡erentiation and plasticity occur
under the control of a complex network of transduction path-
ways ultimately converging to induce activation of the mito-
gen-activated protein kinase (MAPK) signalling cascade [1,2].
Previous studies have shown that Pyk2, a tyrosine kinase
(TK) also called CAKL, RAFTK and CADTK, has a role
in the MAPK response initiated by the increase of the cyto-
solic Ca2, [Ca2]i [3^5]. So far, however, it is not clear
whether the Pyk2 pathway accounts entirely or not for the
latter response and whether the TK is also involved in path-
ways initiated by other types of cell stimuli and/or intracellu-
lar signals.
A direct answer to these question is given here based on
results obtained in a panel of clones isolated from the neuro-
secretory cell line PC12 [6]. One of these clones (PC12-27),
spontaneously defective in Pyk2, was employed as such and
after transfection-induced expression of the TK.
2. Materials and methods
The PC12 line and the clones isolated therefrom (#27, 15 and 37)
were grown in DMEM, 10% horse serum and 5% fetal calf serum (see
[6,7]). PC12-27 cells were transfected with a plasmid containing the
complete open reading frame of Pyk2 [8] using the polyethyleneimine
(25 kDa, Aldrich, Milwaukee, WI, USA) method [9]). Stable sub-
clones were isolated based on their hygromycin resistance. Immuno-
cytochemistry was carried out with the puri¢ed anti-Pyk2 antibody
[10]. Details on ¢xation, embedding and confocal microscope analysis
are given in [7].
For Northern blots, extraction of total RNA was performed ac-
cording to the single step procedure [11]. The hybridization probe
for Pyk2 mRNA (a 1500 base fragment) was excised (at HinDIII sites)
from the TK cDNA [8] labeled with [K32P]dCTP (3000 Ci/mmol,
Redivue, Amersham, UK). Hybridization, washes and autoradiogra-
phy were carried out as in [7].
For Western blots, cells were lysed, and their protein content as-
sayed by the BCA procedure (Pierce, Rockford, IL, USA). Samples
were prepared, run and blotted as in [7]. Anti-Pyk2 immunolabeling
was performed with either the puri¢ed antibody of [10] or the mono-
clonal from Transduction Labs (Lexington, KY, USA). Blots were
developed using the ECL procedure (Redivue, Amersham, UK). Im-
ages were acquired and quantitated using the IMAGEQUANT soft-
ware (Molecular Dynamics, UK).
3. Results and discussion
Several clones of PC12 cells, isolated by the conventional
technique of limiting dilution [6], were screened for Pyk2 ex-
pression by Northern and Western blotting. In all prepara-
tions the levels of Pyk2 mRNA appeared similar (Fig. 1A),
whereas in one clone (#27) Pyk2 protein was inappreciable,
indicating a post-transcriptional defect (Fig. 1B). In two sub-
clones of PC12-27 (#27a and #27b), stably transfected with
the Pyk2 mRNA [7], the expression of Pyk2 protein was re-
stored to levels comparable to the non-defective PC12 cells
(Fig. 1C). These results were con¢rmed by confocal immuno-
cytochemistry. Parental and non-defective PC12 clone cells
exhibited Pyk2 immunoreactivity distributed throughout the
cytoplasm (Fig. 1D), whereas the cells of clone 27 appeared
completely negative (Fig. 1E) and those of the transfected
subclones were indistinguishable from non-defective PC12
cells (Fig. 1F). On the other hand, expression of focal adhe-
sion kinase (FAK), the only other known cytosolic TK closely
related to Pyk2 [5], was found to be similar in all clones,
including PC12-27 (not shown). Apparently, therefore (and
at variance with a clone of ¢broblasts defective in FAK de-
scribed recently [12]), no compensatory increased expression
of the related TK takes place in the Pyk2-defective PC12-27
cells.
Addition to the various PC12 preparations of the Ca2
ionophore, ionomycin (1^3 WM, 5 min, applied in the Ca2-
containing medium), induced [Ca2]i to rise to WM concentra-
tions (see [13] and not shown). Concomitantly, Pyk2 became
tyrosine phosphorylated (and thus activated) in parental and
non-defective clone cells, as revealed by staining with a phos-
phorylation state-speci¢c antibody (not shown). Signalling
consequences of this activation were investigated by studying
MAPKs. Since the levels of one of the family members,
ERK1, were variable from one PC12 clone to another (Fig.
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Fig. 1. Pyk2 Northern (A) and Western (B, C) blots and immunocytochemistry (D^F) in PC12 parental (Par) cells and clones isolated there-
from. Parental (Par) PC12 cells and clones 27, 15 and 37 [6] were used. A: Pyk2 Northern blots. Each lane contains 10 Wg of total RNA. Rep-
resentative of three separate experiments. B: Pyk2 Western blots. Each lane was loaded with 50 Wg protein. Representative of over 10 experi-
ments. C: Western blots as in B, performed on two subclones (27a and 27b) isolated from PC12-27 after stable transfection with Pyk2 cDNA.
D^F: Immunocytochemistry carried out with the puri¢ed anti-Pyk2 antibody [10]. D = parental PC12; E = PC12-27; F = PC12-27a. Magni¢ca-
tion 550U.
Fig. 2. ERK expression in parental PC12, PC12-27 and PC12-27a cells, and ERK phosphorylation of the same cells in response to the indi-
cated treatments. A^C: Western blots performed as in Fig. 1B, using anti-ERK1 and 2 antibody (Zymed, San Francisco, CA, USA). A = paren-
tal PC12; B = PC12-27; C = PC12-27a. D^I: Western blots with anti-active MAPK antibody (Promega, Madison WI, USA) performed as in
Fig. 1B. However, saturation of the nitrocellulose and washes were in PBS with 3% BSA, 0.05% Tween 20. Cells were serum-starved for 18 h
in DMEM, 0.5% horse serum, 0.25% fetal calf serum, then washed in PBS and ¢nally treated with the indicated stimuli for 5 min. Ionomycin
was applied at 1 WM, PMA at 50 nM, ATP at 100 WM. Down-regulation of PKC was induced by treatment with PMA, 50 nM, for 12 h.
D,G = parental PC12; E,H = PC12-27; F,I = PC12-27a. Representative of 3^5 experiments.
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2A and data not shown), we concentrated our attention on
the phosphorylation of the other, ERK2.
The e¡ects of three treatments, with ionomycin, phorbol
myristate acetate (PMA) and a combination of the two, are
illustrated in Fig. 2D^F. In the parental PC12 cells, the ion-
ophore induced a marked phosphorylation of ERK2, similar
to that induced by PMA (Fig. 2D). The e¡ects of the combi-
nation (ionomycin+PMA) were only slightly stronger than
those of ionomycin alone (Fig. 2D). In the Pyk2-defective
PC12-27 cells, no appreciable ERK2 phosphorylation re-
sponse was observed. The response to PMA was relatively
weak, albeit clearly present, with some reinforcement by the
combination with ionomycin (Fig. 2E). In the Pyk2-trans-
fected subclones, the e¡ects of ionomycin were largely re-
stored, and a clear reinforcement of the response was ob-
served in the combined presence of PMA and ionomycin
(Fig. 2F). None of the responses was in£uenced by the pre-
treatment of the cells with the calmodulin antagonist, W7 (50
nM, 10 min) which, in addition, had no appreciable e¡ect on
the level of ERK2 phosphorylation when administered alone
to resting cells (not shown).
In a further series of experiments, the role of protein kinase
C (PKC) in the [Ca2]i-induced responses was examined. In
both the parental cells (Fig. 2G) and the Pyk2-transfected
PC12-27 subclone (Fig. 2I), the ERK2 phosphorylations in-
duced by ionomycin were considerably decreased by pro-
longed pre-exposure to PMA, a treatment which induces the
down-regulation of classical and novel PKCs. Finally, the
response to ATP (known to act through P2y2, a receptor
that in the employed PC12 cells is coupled to phospholipase
C through both pertussis toxin-sensitive and -insensitive G
protein(s), see [13]) was prominent in all three cell types, in-
cluding the defective PC12-27 clone (Fig. 2G^I), with no ap-
preciable change induced by long-term PMA treatment (not
shown).
The role of [Ca2]i in the ATP response of PC12-27 cells
was further studied by using a Ca2-free, EGTA-containing
incubation medium (Fig. 3). In these conditions, prolonged
PMA treatment remained without appreciable e¡ect on the
ATP-induced ERK2 phosphorylation. Only when the PKC
down-regulation was associated with an e⁄cient clamping of
[Ca2]i near the resting level, obtained by pre-loading of the
cells with the chelator BAPTA [14], was the response to ATP
inhibited, however only slightly (Fig. 3).
The results reported here demonstrate that in PC12 cells,
the most widely employed nerve cell model, Pyk2 plays the
key role in the linking of [Ca2]i increase to the MAPK cas-
cade, and thus to the processes regulated thereby. This does
not exclude contributions of other pathways, which however
could only work by modulation of the Pyk2-initiated path-
way. On the other hand, PMA was still able to induce a
MAPK response in the cells defective in Pyk2. This result
excludes Pyk2 as a necessary step in the pathway initiated
by PKC, which therefore appears to operate, at least in
part, in parallel to the Pyk2 pathway.
Of interest were also the results with ATP. The persistence
of the ATP-induced activation of ERK2 in Pyk2-defective
cells indicates that the TK is not necessary for the response
to stimulation of P2Y2 receptors, a conclusion incompatible
with those proposed by others, based however on indirect
evidence [15,16]. Moreover, the results obtained in Pyk2-de-
fective cells with down-regulated PKC and bu¡ered [Ca2]i
exclude the involvement of both PKC and the EGF receptor,
whose transphosphorylation requires high [Ca2]i to occur
[17]. At the moment the pathway(s) sustaining the ATP-in-
duced response remain(s) unde¢ned. Possible participants may
be G protein subunits, K and LQ heterodimers, dissociated by
receptor activation [18^23], working also via the activation of
other TKs, such as Src [20^23], and also FAK, which is nor-
mally expressed in our PC12-27 clone and which is known to
be activated by mechanism(s) di¡erent from those of Pyk2
[10].
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